NCT00978965View on ClinicalTrials.gov

Identification of Patients With High Probability of Poorly Responding to Therapy With Mycophenolic Acid Prodrugs

CompletedOBSERVATIONAL
Enrollment

277

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

September 9, 2020

Study Completion Date

September 9, 2020

Conditions
Renal Transplantation
Interventions
GENETIC

MPA SNP

Functional relevant MPA SNP will be sought in patients DNA isolated from leucocytes

Trial Locations (1)

A-1090

Department of Medicine III, Division of Nephrology, Vienna

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Medical University of Vienna

OTHER